BCI
PRCT icon

Brinker Capital Investments’s Procept Biorobotics PRCT Stock Holding History

Brinker Capital Investments’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$553K Buy
24,501
+7,998
+48% +$200K ﹤0.01% 1420
2026
Q1 		$413K Buy
+16,503
New +$465K ﹤0.01% 1532
2025
Q4 		– Sell
-5,964
Closed -$213K – 2173
2025
Q3 		$213K Sell
5,964
-97
-2% -$4.43K ﹤0.01% 1941
2025
Q2 		$349K Sell
6,061
-763
-11% -$43.1K ﹤0.01% 1637
2025
Q1 		$398K Buy
6,824
+239
+4% +$16.3K ﹤0.01% 1506
2024
Q4 		$530K Buy
+6,585
New +$563K 0.01% 1327

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Brinker Capital Investments's PRCT Position: Q2 2026 in Review

Brinker Capital Investments increased its Procept Biorobotics (PRCT) stake by 48% in Q2 2026, buying an estimated $200K and bringing the position to 24,501 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

Brinker Capital Investments first reported a position in PRCT in Q4 2024 and has held it in 6 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Brinker Capital Investments held 24,501 shares of Procept Biorobotics worth $553K as of Q2 2026.
  • Brinker Capital Investments bought 7,998 Procept Biorobotics shares in Q2 2026, an estimated $200K.
  • Procept Biorobotics made up ﹤0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1420 holding.
  • Brinker Capital Investments first reported a position in Procept Biorobotics in Q4 2024 and has held it in 6 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.